IAIM
ACAD icon

International Assets Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

International Assets Investment Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-300
Closed -$16K – 506
2021
Q1 		$16K Hold
300
– – ﹤0.01% 1374
2020
Q4 		$16K Buy
+300
New +$14.9K ﹤0.01% 1242

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

International Assets Investment Management's ACAD Position: Q2 2021 in Review

International Assets Investment Management sold out of Acadia Pharmaceuticals (ACAD) in Q2 2021, closing a stake of 300 shares — an estimated $16K sold.

International Assets Investment Management first reported a position in ACAD in Q4 2020 and held it in 2 quarters. The position peaked at $16K in Q1 2021. 245 funds tracked by Wall St. Rank hold ACAD as of Q2 2021.

  • International Assets Investment Management reported no remaining Acadia Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • International Assets Investment Management sold 300 Acadia Pharmaceuticals shares in Q2 2021, an estimated $16K.
  • International Assets Investment Management first reported a position in Acadia Pharmaceuticals in Q4 2020 and held it in 2 quarters.
  • International Assets Investment Management's Acadia Pharmaceuticals position peaked at $16K in Q1 2021.
  • 245 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2021.

Based on International Assets Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.